II-VI Incorporated develops, manufactures, and markets engineered materials, and optoelectronic components and devices worldwide. The company operates in three segments: II-VI Laser Solutions, II-VI Photonics, and II-VI Performance Products. The II-VI Laser Solutions segment offers optical and electro-optical components and materials primarily used in high-power CO2 lasers; fiber-delivered beam delivery systems, and processing tools and direct diode lasers for industrial lasers; direct diode laser modules, sub-systems, and systems; super-hard materials processing laser systems; and compound se... view company details
Parkwaycorp is a provider of real estate and parking operator services. view company details
Schlotzsky's is a fast-food operator and franchisor with 350 units nationwide specializing in sandwiches. view company details
American Tower, one of the largest global REITs, is a leading independent owner, operator and developer of multitenant communications real estate with a portfolio of over 170,000 communications sites. view company details
Saker Aviation Services, Inc., through its subsidiaries, operates in the aviation services segment of the general aviation industry in the United States. The company serves as the operator of a heliport, a fixed base operation (FBO); a provider of aircraft maintenance and repair services (MRO); and a consultant for a seaplane base. It also provides ground-based services, such as fueling and aircraft storage for general aviation, commercial, and military aircraft, as well as other miscellaneous services. Its business activities are carried out as the operator of the Downtown Manhattan (New York... view company details
SBA Communications Corporation is a first choice provider and leading owner and operator of wireless communications infrastructure in North, Central, and South America. By 'Building Better Wireless,' SBA generates revenue from two primary businesses - site leasing and site development services. The primary focus of the Company is the leasing of antenna space on its multi-tenant communication sites to a variety of wireless service providers under long-term lease contracts. view company details
TRACON Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for cancer and wet age-related macular degeneration (AMD). Its lead product candidate is TRC105, an endoglin antibody, which is in randomized Phase III clinical trial for angiosarcoma; Phase I/II clinical trial for hepatocellular carcinoma; Phase I clinical trial for lung cancer; Phase I/II clinical trial for breast cancer; Phase II clinical trials for prostate cancer; and randomized Phase II clinical trial for wet AMD. The company also develops TRC102, a small molecule t... view company details
Epizyme, Inc., a late-stage biopharmaceutical company, discovers, develops, and commercializes novel epigenetic medicines for patients with cancer and other diseases primarily in the United States. The company's lead products candidate is tazemetostat, an inhibitor of the EZH2 histone methyltransferase, which is in the Phase II clinical trial for patients with relapsed or refractory non-hodgkin lymphoma (NHL); Phase II clinical trial for relapsed or refractory patients with mesothelioma characterized by BAP1 loss-of-function; and Phase II clinical trial for adults and Phase I clinical trial fo... view company details
Applied Genetic Technologies Corporation, a clinical-stage biotechnology company, develops transformational genetic therapies for patients suffering from rare and debilitating diseases. The company's lead products consist of four ophthalmology development programs across three targets, including X-linked retinoschisis that is in Phase I/II clinical trials; X-linked retinitis pigmentosa, which is in Phase I/II clinical trials; and achromatopsia that is in Phase I/II clinical trials for the treatment of inherited retinal diseases, as well as a preclinical program in adrenoleukodystrophy, which i... view company details
Zynerba Pharmaceuticals, Inc. operates as a clinical stage specialty pharmaceutical company. It focuses on developing pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders. The company is developing Zygel, a transdermal cannabidiol gel, which is in Phase II clinical trial for treating children and adolescent patients with developmental and epileptic encephalopathies; is in Phase II/III clinical trial to treat children and adolescent patients with fragile X syndrome; and is in Phase II clinical trial for treating children and adolescent pa... view company details
Axsome Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in developing novel therapies for central nervous system (CNS) disorders in the United States. Its product pipeline includes AXS-05, which is in the Phase III clinical trial for the treatment resistant depression; Phase II/III clinical trials in agitation associated with Alzheimer's disease; and Phase II clinical trial for the treatment of smoking cessation, as well as for major depressive disorder. The company is also developing AXS-07, which is in Phase III clinical trial for the treatment of migraine; AXS-12 that... view company details
Karyopharm Therapeutics Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of drugs directed against nuclear transport and related targets for the treatment of cancer and other diseases. Its lead drug candidate is Selinexor(KPT-330), which is in Phase IIb clinical study in treatments of refractory multiple myeloma; Phase Ib/II clinical study in combination with backbone treatments for multiple myeloma patients; Phase III clinical trial in combination with Velcade (bortezomib) and dexamethasone for multiple myeloma patients; Phase IIb cli... view company details
REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprietary adeno-associated virus (AAV) gene delivery platform. The company's lead product candidate is RGX-314, which is in Phase I/IIa clinical trials for the treatment of wet age-related macular degeneration. It is also developing RGX-121 that is in Phase ... view company details
Since 1960 ACME TRUCK LINE has been a leader in the transportation of equipment, materials, and supplies throughout the United States. ACME is the largest oilfield carrier in America. This is a 100% owner/operator fleet comprised of over 2,000 trucks. ACME offers expedited hauls, truck loads, heavy hauls, tow away, drive away, bulk and 3PL services. They operate in more than fifty service markets in seven states, 24 hours per day, 365 days each year. ACME is an employee-owned company and drivers receive benefits (health insurance and 401Ks). view company details
AirQuest Aviation is a Fixed Base Operator, (FBO). We are located at the Butler County Airport (KBTP) in Butler,Pennsylvania. We are proud to provide premiere aviation support such as flight training, aircraft rental, aircraft sales, aircharter, aircraft maintenance, fuel sales and a wide variety of concierge services. Our services, however, go beyond our customer's expectations. We are devoted to customer service and commitment in doing whatever it takes to accommodate our client's flights. view company details
CIM Commercial is a real estate investment trust that primarily acquires, owns, and operates Class A and creative office assets in vibrant and improving metropolitan communities throughout the United States. Its properties are primarily located in Los Angeles, the San Francisco Bay Area and Washington, D.C. CIM Commercial is operated by affiliates of CIM Group, L.P., a vertically-integrated owner and operator of real assets with multi-disciplinary expertise and in-house research, acquisition, credit analysis, development, finance, leasing, and onsite property management capabilities. view company details
Cardtronics is the world's largest ATM owner / operator. Whether Cardtronics is driving foot traffic for North America's and Europe's top retailers, enhancing ATM brand presence for financial institutions or expanding cardholders' surcharge-free cash access, Cardtronics is convenient access to cash, when and where consumers need it. Cardtronics also owns and operates Allpoint Network'the largest surcharge-free ATM network'which helps financial institutions and prepaid card programs connect consumers with surcharge-free cash access at more than 55,000 ATMs in North America and Europe. For more ... view company details
Cedarhurst Senior Living is an experienced operator of Independent Living, Assisted Living, Personal Care, and Memory Care communities under the Cedarhurst Senior Living, Addington Place, and Camellia Walk brands. Cedarhurst is part of The Dover Companies, established in 2007 to develop, construct, own and operate high-quality senior housing. Cedarhurst Senior Living operates 36 communities in Illinois, Missouri, Kansas, Georgia, Oklahoma, and Florida and currently has seven new communities under construction. The senior living provider's mission is to positively transform the lives of seniors... view company details
CIM is a community-focused real estate and infrastructure owner, operator, lender and developer. Our in-house team of experts works together to identify and create value in real assets, benefiting the communities in which we invest. Back in 1994, our three founders focused on projects in Southern California neighborhoods. Today, we're a diverse team of more than 990 employees with projects across the Americas. Our projects have delivered jobs; created comfortable places to live, work and relax; and provided necessary and sustainable infrastructure. Our focus on enhancing communities is unwaver... view company details